{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:39:05Z","timestamp":1773286745108,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81101140"],"award-info":[{"award-number":["81101140"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.antiviral.2012.10.002","type":"journal-article","created":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T00:07:56Z","timestamp":1350518876000},"page":"324-332","source":"Crossref","is-referenced-by-count":11,"title":["Characterization of an attenuated TE3L-deficient vaccinia virus Tian Tan strain"],"prefix":"10.1016","volume":"96","author":[{"given":"Yuhang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shifu","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouwen","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongyun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baorong","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningyi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.antiviral.2012.10.002_b0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00370005","article-title":"Host-range restriction of vaccinia virus E3L-specific deletion mutants","volume":"12","author":"Beattie","year":"1996","journal-title":"Virus Genes"},{"key":"10.1016\/j.antiviral.2012.10.002_b0010","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.antiviral.2012.10.002_b0015","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1128\/JVI.74.9.4085-4092.2000","article-title":"The vaccinia virus A14.5L gene encodes a hydrophobic 53-amino-acid virion membrane protein that enhances virulence in mice and is conserved among vertebrate poxviruses","volume":"74","author":"Betakova","year":"2000","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2012.10.002_b0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.virol.2005.01.006","article-title":"The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response","volume":"333","author":"Brandt","year":"2005","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.antiviral.2012.10.002_b0025","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1128\/JVI.75.2.850-856.2001","article-title":"Both carboxyl- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model","volume":"75","author":"Brandt","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.10.002_b0030","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/JVI.62.3.866-874.1988","article-title":"Deletion of the vaccinia virus growth factor gene reduces virus virulence","volume":"62","author":"Buller","year":"1988","journal-title":"Viral"},{"issue":"6040","key":"10.1016\/j.antiviral.2012.10.002_b0035","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/317813a0","article-title":"Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype","volume":"317","author":"Buller","year":"1985","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.antiviral.2012.10.002_b0040","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2003.11.053","article-title":"Smallpox vaccination and myopericarditis: a clinical review","volume":"43","author":"Cassimatis","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.antiviral.2012.10.002_b0045","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1073\/pnas.89.11.4825","article-title":"The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase","volume":"89","author":"Chang","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"13","key":"10.1016\/j.antiviral.2012.10.002_b0050","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1128\/JVI.00116-06","article-title":"Obligatory requirement for antibody in recovery from a primary poxvirus infection","volume":"80","author":"Chaudhri","year":"2006","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2012.10.002_b0055","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/JVI.80.5.2127-2140.2006","article-title":"Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles","volume":"80","author":"Chung","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2012.10.002_b0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1099\/vir.0.81417-0","article-title":"Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy","volume":"87","author":"Clark","year":"2006","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2012.10.002_b0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virol.2005.06.043","article-title":"The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection","volume":"341","author":"Coulibaly","year":"2005","journal-title":"Virology"},{"issue":"52","key":"10.1016\/j.antiviral.2012.10.002_b0070","doi-asserted-by":"crossref","first-page":"9684","DOI":"10.1016\/j.vaccine.2011.09.135","article-title":"Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques","volume":"29","author":"Denzler","year":"2011","journal-title":"Vaccine"},{"issue":"44","key":"10.1016\/j.antiviral.2012.10.002_b0075","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1016\/j.vaccine.2011.07.140","article-title":"The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus","volume":"29","author":"Denzler","year":"2011","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.antiviral.2012.10.002_b0080","doi-asserted-by":"crossref","first-page":"9691","DOI":"10.1016\/j.vaccine.2011.09.108","article-title":"The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus","volume":"29","author":"Denzler","year":"2011","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.antiviral.2012.10.002_b0085","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1016\/j.vaccine.2011.05.088","article-title":"Enhancement of immune response to an antigen delivered by vaccinia virus by displaying the antigen on the surface of intracellular mature virion","volume":"29","author":"Embry","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.antiviral.2012.10.002_b0090","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.virol.2005.02.014","article-title":"Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain","volume":"335","author":"Fang","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.10.002_b0095","series-title":"Smallpox and Its Eradication","year":"1988"},{"issue":"2","key":"10.1016\/j.antiviral.2012.10.002_b0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/gt.2009.132","article-title":"Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumours","volume":"17","author":"Hiley","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.antiviral.2012.10.002_b0105","doi-asserted-by":"crossref","unstructured":"Isaacs, S.N. (Ed.), 2004. Vaccinia Virus and Poxvirology Methods and Protocols. Methods in Molecular Biology. 269 vols. Humana Press.","DOI":"10.1385\/1592597890"},{"issue":"17","key":"10.1016\/j.antiviral.2012.10.002_b0110","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.1128\/JVI.00624-06","article-title":"The envelope G3L protein is essential for entry of vaccinia virus into host cells","volume":"80","author":"Izmailyan","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2012.10.002_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2009.06.006","article-title":"Vaccinia virus vaccines: past, present and future","volume":"84","author":"Jacobs","year":"2009","journal-title":"Antiviral Res."},{"issue":"23","key":"10.1016\/j.antiviral.2012.10.002_b0120","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.vaccine.2008.03.044","article-title":"Vaccinia viruses with mutations in the E3L gene as potential replication-competent attenuated vaccines: scarification vaccination","volume":"26","author":"Jentarra","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.antiviral.2012.10.002_b0125","doi-asserted-by":"crossref","first-page":"e31979","DOI":"10.1371\/journal.pone.0031979","article-title":"Attenuation of Vaccinia Tian Tan Strain by Removal of Viral TC7L-TK2L and TA35R Genes","volume":"7","author":"Kan","year":"2012","journal-title":"PLoS ONE"},{"issue":"47\u201348","key":"10.1016\/j.antiviral.2012.10.002_b0130","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","article-title":"LC16m8: an attenuated smallpox vaccine","volume":"24","author":"Kenner","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.antiviral.2012.10.002_b0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/viro.2002.1479","article-title":"The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range","volume":"299","author":"Langland","year":"2002","journal-title":"Virology"},{"issue":"20","key":"10.1016\/j.antiviral.2012.10.002_b0140","doi-asserted-by":"crossref","first-page":"10083","DOI":"10.1128\/JVI.00607-06","article-title":"Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins","volume":"80","author":"Langland","year":"2006","journal-title":"J. Virol."},{"issue":"22","key":"10.1016\/j.antiviral.2012.10.002_b0145","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1007\/s11434-006-2176-z","article-title":"Construction and anti-tumor effects of recombinant fowlpox virus expressing newcastle disease virus hemagglutinin\u2013neuramidinase gene","volume":"51","author":"Li","year":"2006","journal-title":"Chin. Sci. Bull."},{"issue":"12","key":"10.1016\/j.antiviral.2012.10.002_b0150","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1002\/ijc.22215","article-title":"Antitumor effects of a recombinant fowlpox virus expressing Apoptin in vivo and in vitro","volume":"119","author":"Li","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.antiviral.2012.10.002_b0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2005.06.002","article-title":"Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model","volume":"339","author":"Meseda","year":"2005","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.antiviral.2012.10.002_b0160","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2012.10.002_b0165","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.antiviral.2012.10.002_b0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.virol.2007.04.010","article-title":"DNA\/MVA HIV-1\/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge","volume":"366","author":"Nigam","year":"2007","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.antiviral.2012.10.002_b0175","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/JVI.01802-09","article-title":"The poxvirus A35 protein is an immunoregulator","volume":"84","author":"Rehm","year":"2010","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.antiviral.2012.10.002_b0180","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1016\/j.vaccine.2011.02.023","article-title":"Deletion of the A35 gene from modified vaccinia virus Ankara increases immunogenicity and isotype switching","volume":"29","author":"Rehm","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2012.10.002_b0185","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1006\/viro.1998.9072","article-title":"Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2\u20135A synthetase enzyme","volume":"243","author":"Rivas","year":"1998","journal-title":"Virology"},{"issue":"13\u201314","key":"10.1016\/j.antiviral.2012.10.002_b0190","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0264-410X(00)00416-3","article-title":"Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaques","volume":"19","author":"Rosenwirth","year":"2001","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.antiviral.2012.10.002_b0195","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1074\/jbc.M008717200","article-title":"IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by vaccinia virus E3L protein","volume":"276","author":"Smith","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.antiviral.2012.10.002_b0200","doi-asserted-by":"crossref","first-page":"9842","DOI":"10.1128\/JVI.78.18.9842-9853.2004","article-title":"A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag\/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity","volume":"78","author":"Someya","year":"2004","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2012.10.002_b0205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0042-6822(92)90752-B","article-title":"NYVAC: a highly attenuated strain of vaccinia virus","volume":"188","author":"Tartaglia","year":"1992","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.antiviral.2012.10.002_b0210","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/gt.2009.74","article-title":"Lister strain of vaccinia virus armed with endostatin\u2013angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer","volume":"16","author":"Tysome","year":"2009","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.antiviral.2012.10.002_b0215","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.vaccine.2007.11.045","article-title":"Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination","volume":"26","author":"Vijaysri","year":"2008","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.antiviral.2012.10.002_b0220","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1128\/JVI.06889-11","article-title":"The amino terminus of the vaccinia virus E3 protein is necessary to inhibit the interferon response","volume":"86","author":"White","year":"2012","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.antiviral.2012.10.002_b0225","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/01.all.0000136758.66442.28","article-title":"Smallpox, vaccination and adverse reactions to smallpox vaccine","volume":"4","author":"Wollenberg","year":"2004","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.antiviral.2012.10.002_b0230","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.4049\/jimmunol.172.10.6265","article-title":"Cellular and humoral immunity against vaccinia virus infection of mice","volume":"172","author":"Xu","year":"2004","journal-title":"J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.antiviral.2012.10.002_b0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jviromet.2007.03.012","article-title":"The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L\u2013K2L genes","volume":"144","author":"Zhu","year":"2007","journal-title":"J. Virol. Methods"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421200232X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421200232X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T22:27:47Z","timestamp":1594765667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421200232X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S016635421200232X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2012.10.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}